The efficacy and safety of PI3K and AKT inhibitors for patients with cancer: A systematic review and network meta-analysis.
Saved in:
| Title: | The efficacy and safety of PI3K and AKT inhibitors for patients with cancer: A systematic review and network meta-analysis. |
|---|---|
| Authors: | Zhang, Yingshi1,2 (AUTHOR) zhangyingshi@syphu.edu.cn, Xu, Xiangbo1,2 (AUTHOR) xxb_1104@sina.cn, Yang, Kaisi1,2 (AUTHOR) syphuyks100@163.com, Wang, Shuai1,2 (AUTHOR) ws322577@163.com, Zhang, Tianqi1,2 (AUTHOR) 18940967573@163.com, Hui, Fuhai2 (AUTHOR) huifuhai@163.com, Zheng, Fangyuan1,2 (AUTHOR) zhengfangyuanzxq@163.com, Geng, Hefeng1,2 (AUTHOR) x876892517@163.com, Xu, Chang1,2 (AUTHOR) Charlottexu1996@163.com, Xun, Fanghua1,3 (AUTHOR) 15690510226@163.com, Xu, Ziang1,2 (AUTHOR) Xza13842350393@163.com, Wang, Chengkang1,2 (AUTHOR) W1877816073@outlook.com, Hou, Shanbo4 (AUTHOR) shanbohou@luoxin.cn, Song, Aigang4 (AUTHOR) aigangsong@luoxin.cn, Ren, Tianshu1,2 (AUTHOR) sz_pharm@163.com, Zhao, Qingchun1,2 (AUTHOR) zhaoqingchun1967@163.com |
| Source: | European Journal of Pharmacology. Nov2024, Vol. 983, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 180132617 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The efficacy and safety of PI3K and AKT inhibitors for patients with cancer: A systematic review and network meta-analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Zhang%2C+Yingshi%22">Zhang, Yingshi</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> zhangyingshi@syphu.edu.cn</i><br /><searchLink fieldCode="AR" term="%22Xu%2C+Xiangbo%22">Xu, Xiangbo</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> xxb_1104@sina.cn</i><br /><searchLink fieldCode="AR" term="%22Yang%2C+Kaisi%22">Yang, Kaisi</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> syphuyks100@163.com</i><br /><searchLink fieldCode="AR" term="%22Wang%2C+Shuai%22">Wang, Shuai</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> ws322577@163.com</i><br /><searchLink fieldCode="AR" term="%22Zhang%2C+Tianqi%22">Zhang, Tianqi</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> 18940967573@163.com</i><br /><searchLink fieldCode="AR" term="%22Hui%2C+Fuhai%22">Hui, Fuhai</searchLink><relatesTo>2</relatesTo> (AUTHOR)<i> huifuhai@163.com</i><br /><searchLink fieldCode="AR" term="%22Zheng%2C+Fangyuan%22">Zheng, Fangyuan</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> zhengfangyuanzxq@163.com</i><br /><searchLink fieldCode="AR" term="%22Geng%2C+Hefeng%22">Geng, Hefeng</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> x876892517@163.com</i><br /><searchLink fieldCode="AR" term="%22Xu%2C+Chang%22">Xu, Chang</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> Charlottexu1996@163.com</i><br /><searchLink fieldCode="AR" term="%22Xun%2C+Fanghua%22">Xun, Fanghua</searchLink><relatesTo>1,3</relatesTo> (AUTHOR)<i> 15690510226@163.com</i><br /><searchLink fieldCode="AR" term="%22Xu%2C+Ziang%22">Xu, Ziang</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> Xza13842350393@163.com</i><br /><searchLink fieldCode="AR" term="%22Wang%2C+Chengkang%22">Wang, Chengkang</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> W1877816073@outlook.com</i><br /><searchLink fieldCode="AR" term="%22Hou%2C+Shanbo%22">Hou, Shanbo</searchLink><relatesTo>4</relatesTo> (AUTHOR)<i> shanbohou@luoxin.cn</i><br /><searchLink fieldCode="AR" term="%22Song%2C+Aigang%22">Song, Aigang</searchLink><relatesTo>4</relatesTo> (AUTHOR)<i> aigangsong@luoxin.cn</i><br /><searchLink fieldCode="AR" term="%22Ren%2C+Tianshu%22">Ren, Tianshu</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> sz_pharm@163.com</i><br /><searchLink fieldCode="AR" term="%22Zhao%2C+Qingchun%22">Zhao, Qingchun</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> zhaoqingchun1967@163.com</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22European+Journal+of+Pharmacology%22">European Journal of Pharmacology</searchLink>. Nov2024, Vol. 983, pN.PAG-N.PAG. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=180132617 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ejphar.2024.176952 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: N.PAG Titles: – TitleFull: The efficacy and safety of PI3K and AKT inhibitors for patients with cancer: A systematic review and network meta-analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zhang, Yingshi – PersonEntity: Name: NameFull: Xu, Xiangbo – PersonEntity: Name: NameFull: Yang, Kaisi – PersonEntity: Name: NameFull: Wang, Shuai – PersonEntity: Name: NameFull: Zhang, Tianqi – PersonEntity: Name: NameFull: Hui, Fuhai – PersonEntity: Name: NameFull: Zheng, Fangyuan – PersonEntity: Name: NameFull: Geng, Hefeng – PersonEntity: Name: NameFull: Xu, Chang – PersonEntity: Name: NameFull: Xun, Fanghua – PersonEntity: Name: NameFull: Xu, Ziang – PersonEntity: Name: NameFull: Wang, Chengkang – PersonEntity: Name: NameFull: Hou, Shanbo – PersonEntity: Name: NameFull: Song, Aigang – PersonEntity: Name: NameFull: Ren, Tianshu – PersonEntity: Name: NameFull: Zhao, Qingchun IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 11 Text: Nov2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 00142999 Numbering: – Type: volume Value: 983 Titles: – TitleFull: European Journal of Pharmacology Type: main |
| ResultId | 1 |
